RSS Feed
Featured Posts

Canadian researchers team up to find a cure to childhood cancer

Researchers will sequence tumours at the molecular level to amass information that is then analyzed at one of three labs in Vancouver, Toronto and Montreal. The aim is to be able to create personalized treatment for patients with tumours that are difficult to treat with conventional therapy — no matter where they live in Canada. Read more:

Introducing a new Family Caregiver benefit for children

We have made it easier to access benefits for the care of critically ill children under 18. Starting December 3, 2017, any family member or person who is considered to be like family will be eligible for this renamed and enhanced Family Caregiver benefit for children. (Before, the Parents of Critically Ill Children benefit was available only to parents.) Up to 35 weeks of EI benefits will continue to be available for the care of a critically ill child. Medical doctors and nurse practitioners will be able to sign the certificate stating that the child is critically ill. (Before, the certificate had to be signed by a medical specialist.) Read more:

Brain cancer treatment previously featured on 60 Minutes now available to children

A Phase 1 clinical trial leveraging the re-engineered polio virus is now open for enrollment to children 12 years and older at the Preston Robert Tisch Brain Tumor Center, Duke University Medical Center. After years of following the progress of this promising therapy against adult glioblastoma and working with the research team on behalf of children, Solving Kids' Cancer teamed up with The Andrew McDonough B+ Foundation to help move this forward in a trial for pediatric brain tumor patients. Read more:

Back to School After a Cancer Diagnosis

Fighting the disease can present challenges to kids in the classroom. But there are resources to help. Read more:

Liquid biopsy spots aggressive pediatric brainstem cancer earlier without surgery

A particularly aggressive form of pediatric cancer can be spotted reliably by the genetic fragments it leaves behind in children's biofluids, opening the door to non-surgical biopsies and providing a way to gauge whether such tumors respond to treatment, according to researchers. Read more:

FDA approves dasatinib for children with Philadelphia chromosome-positive chronic myeloid leukemia

The FDA expanded the indication for dasatinib to include the treatment of children with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. Read more:

Parental exposure to hazardous agents tied to eye tumors in offspring

Parents’ exposure to chemicals at work might be linked to eye cancer in their children, a report from some of the world’s leading childhood cancer experts suggests. Read more:

Old drug, new trick: study finds common diabetes drug could help fight leukemia

Researchers have discovered a new potential treatment for acute myeloid leukemia (AML). They found that boosting fat cells (adipocytes) within bone marrow with the use of a common diabetes drug slowed the growth of cancerous cells and promoted the regeneration of healthy blood cells. Read more:

Researchers find fatal flaw in childhood tumors

Childhood tumors aren’t duplicates of their adult counterparts. They often carry distinct mutations, respond differently to drugs, and stem from other causes. Those are some of the reasons that only four new drugs for treating cancer in children have received approval from the U.S. Food and Drug Administration in the past 25 years, versus more than 100 drugs for adult cancers. Now, researchers say they’ve found a new way to fight cancer in children, one that targets a tumor cell’s ability to repair its DNA. Read more:

Recent Posts
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • YouTube Social  Icon

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9


  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon